0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.45%
Negative revenue growth while 0259.HK stands at 20.26%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-61.53%
Negative gross profit growth while 0259.HK is at 89.87%. Joel Greenblatt would examine cost competitiveness or demand decline.
-496.72%
Negative EBIT growth while 0259.HK is at 169.28%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-496.72%
Negative operating income growth while 0259.HK is at 169.28%. Joel Greenblatt would press for urgent turnaround measures.
-64.24%
Negative net income growth while 0259.HK stands at 33.91%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-27.12%
Negative EPS growth while 0259.HK is at 34.53%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-27.12%
Negative diluted EPS growth while 0259.HK is at 34.15%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
29.22%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
29.28%
Slight or no buyback while 0259.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while 0259.HK stands at 5.78%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.10%
Negative OCF growth while 0259.HK is at 101.15%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.79%
Negative FCF growth while 0259.HK is at 204.25%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-48.70%
Negative 10Y revenue/share CAGR while 0259.HK stands at 96.89%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-49.30%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-53.69%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-963.10%
Negative 10Y OCF/share CAGR while 0259.HK stands at 2211.46%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-956.34%
Negative 5Y OCF/share CAGR while 0259.HK is at 81.95%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.05%
Negative 3Y OCF/share CAGR while 0259.HK stands at 9332.59%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-208.22%
Negative 10Y net income/share CAGR while 0259.HK is at 228.07%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-514.36%
Negative 5Y net income/share CAGR while 0259.HK is 13.92%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-282.74%
Negative 3Y CAGR while 0259.HK is 8.27%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
135.21%
10Y equity/share CAGR above 1.5x 0259.HK's 27.94%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-6.80%
Negative 5Y equity/share growth while 0259.HK is at 64.61%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.90%
Negative 3Y equity/share growth while 0259.HK is at 18.23%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0259.HK stands at 899.96%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0259.HK stands at 25.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-5.13%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
22.07%
Inventory growth well above 0259.HK's 20.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.37%
Similar asset growth to 0259.HK's 9.90%. Walter Schloss finds parallel expansions or investment rates.
-26.90%
We have a declining book value while 0259.HK shows 6.59%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
73.53%
We have some new debt while 0259.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-37.45%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-33.04%
We cut SG&A while 0259.HK invests at 2.36%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.